Score Overview
Explore the 2021 public Archive ranking →
Where Biomerica Inc has ranked, year by year
Showing 10 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- BMRA
2016: 98.3% · 2021: 97.7% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-29 | $ 2.30 | — |
1 Year2025-09-29 | $ 2.85 | -19.30% |
5 Years2021-09-29 | $ 37.28 | -93.83% |
10 Years2016-09-29 | $ 21.44 | -89.27% |
20 Years2006-09-29 | $ 4.16 | -44.71% |
30 Years1996-09-27 | $ 38.00 | -93.95% |
All Time2005-01-03 | $ 3.20 | -28.13% |
| Period | Last Price2026-09-29 | 1 Year2025-09-29 | 5 Years2021-09-29 | 10 Years2016-09-29 | 20 Years2006-09-29 | 30 Years1996-09-27 | All Time2005-01-03 |
|---|---|---|---|---|---|---|---|
| Price | $ 2.30 | $ 2.85 | $ 37.28 | $ 21.44 | $ 4.16 | $ 38.00 | $ 3.20 |
| Return | — | -19.30% | -93.83% | -89.27% | -44.71% | -93.95% | -28.13% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| 2026 | $ 4M | -$ 3M | $ 1M |
| 2025 | $ 5M | -$ 4M | $ 2M |
| 2024 | $ 5M | -$ 5M | $ 4M |
| 2023 | $ 5M | -$ 7M | $ 9M |
| 2022 | $ 18M | -$ 4M | $ 5M |
| 2021 | $ 7M | -$ 7M | $ 4M |
| 2020 | $ 6M | -$ 2M | $ 8M |
| 2019 | $ 5M | -$ 2M | $ 686.78K |
| 2018 | $ 5M | -$ 1M | $ 1M |
| 2017 | $ 5M | -$ 908.56K | $ 1M |
| 2016 | $ 5M | -$ 1M | $ 1M |
| 2015 | $ 4M | -$ 331.41K | $ 1M |
| 2014 | $ 5M | -$ 215.66K | $ 1M |
| 2013 | $ 6M | $ 536.96K | $ 2M |
| 2012 | $ 6M | $ 548.43K | $ 1M |
| 2011 | $ 4M | $ 157.45K | $ 989.27K |
| 2010 | $ 5M | -$ 331.45K | $ 1M |
| 2009 | $ 4M | $ 354.18K | $ 1M |
| 2008 | $ 4M | $ 1M | $ 2M |
| 2007 | $ 5M | $ 536.88K | $ 517.43K |
| 2006 | $ 7M | $ 230.27K | $ 123.19K |
| IPO2005 | $ 9M | $ 162.26K | $ 360.06K |
Biomerica Inc fundamental performance
Between 2021 and 2026, revenue declined from $ 7M to $ 4M and net income went from -$ 7M to -$ 3M. Revenue increased in 2 of those 5 years; net income in 4.
Between 2016 and 2026, revenue declined from $ 5M to $ 4M and net income went from -$ 1M to -$ 3M. Revenue increased in 5 of those 10 years; net income in 6.
Biomerica Inc currently holds a 20-year HDB Score of 2.1 out of 10. How the HDB Score is calculated.
Membership
Continue BMRA’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
